Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Economic efficiency in lowering healthcare costs is another important factor, especially in chronic diseases such as type 2 diabetes and obesity
Taurine functions as a neuromodulator by altering GABAergic activity
When you stop, ghrelin rises again, and that enhanced sensitivity fades
("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced positive results from the company's Phase 1 multiple ascending dose (MAD) clinical trial of an oral tablet formulation of VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, in development for the potential treatment of metabolic disorders such as obesity
3) produces research findings with generality that can be easily extrapolated to other contexts
US$ 26.17
US$ 23.76
US$ 20.74
US$ 29.42
US$ 27.30
US$ 25.43
US$ 29.76
